You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

systemic lymphoma with a history of treated CNS lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Lymphoma Cns Trial in Boston (Fludarabine, Cyclophosphamide, Axicabtagene Ciloleucel)

Recruiting
  • Lymphoma
  • Lymphoma Cns
  • Boston, Massachusetts
  • +1 more
Jan 3, 2023

Adult Patients Who Initiate Systemic Treatment for Relapsed or

Recruiting
  • Relapsed/Refractory Follicular Lymphoma
  • Non-Interventional
  • Graz, Austria
  • +8 more
Sep 19, 2022

Adult Patients Who Initiate Systemic Treatment for

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Non-Interventional
  • Graz, Austria
  • +8 more
Sep 19, 2022

CNS Lymphoma Trial in Berlin (Voraxaze Injectable Product)

Recruiting
  • CNS Lymphoma
  • Voraxaze Injectable Product
  • Berlin, Germany
    Charité Campus Benjamin Franklin (CBF)
Jul 18, 2022

Prospective Neurobehavioral Functions in Newly-diagnosed Primary

Recruiting
  • Primary CNS Lymphoma
  • Brain Lymphoma
  • A treatment protocol of combined chemoradiation delivered in the manner of hyperfractionated conformal whole-brain radiation therapy
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital
Mar 9, 2021

Pediatric Cancer, Leukemia, Tumors Trial in Aarhus, Copenhagen, Odense (Integrative neuromuscular training (INT), Active control

Recruiting
  • Pediatric Cancer
  • +5 more
  • Integrative neuromuscular training (INT)
  • +2 more
  • Aarhus, Denmark
  • +2 more
Mar 23, 2022

Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in

Recruiting
  • Myelodysplastic Syndrome
  • +16 more
  • Computed Tomography
  • +6 more
  • Scottsdale, Arizona
  • +2 more
Feb 3, 2022

Primary CNS Lymphoma Patients Treated With Cranial Radiotherapy

Recruiting
  • Primary Central Nervous System Lymphoma
  • Standard treatment protocol with combined chemoradiation
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital
Mar 9, 2021

Primary Mediastinal Large B-cell Lymphoma With CNS Involvement

Recruiting
  • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
    • Milan, Italy
      Ospedale San Raffaele
    Aug 29, 2023

    Primary CNS Lymphoma Trial in Paris (PET-MRI)

    Not yet recruiting
    • Primary Central Nervous System Lymphoma
    • Paris, France
      Hôpital Pitié Salpêtrière
    May 20, 2022

    CNS Lymphoma, Primary CNS Lymphoma, Secondary CNS Lymphoma Trial in San Francisco (Tafasitamab, Lenalidomide)

    Recruiting
    • CNS Lymphoma
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Aug 10, 2022

    CNS Lymphoma Trial in Chapel Hill, Winston-Salem (Acalabrutinib, Isavuconazole)

    Recruiting
    • Central Nervous System Lymphoma
    • Chapel Hill, North Carolina
    • +1 more
    Mar 24, 2022

    Lymphoma, Non-Hodgkin, HIV Trial in New Orleans (Methotrexate, Leucovorin calcium, Zidovudine)

    Terminated
    • Lymphoma, Non-Hodgkin
    • HIV Infections
    • New Orleans, Louisiana
      Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU
    Oct 27, 2021

    Primary CNS Lymphoma Trial in London (CD19CAR T-cells)

    Recruiting
    • Primary CNS Lymphoma
    • CD19CAR T-cells
    • London, United Kingdom
      University College London Hospital
    Jun 13, 2022

    Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

    Recruiting
    • Adenocarcinoma
    • +75 more
    • Biomarker Testing (L)
    • +2 more
    • Idaho Falls, Idaho
    • +1 more
    Oct 18, 2022

    Primary Diffuse Large B-cell Lymphoma of the CNS (CNS), Aggressive B-cell Lymphoma With Secondary Involvement of the CNS Trial

    Suspended
    • Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS)
    • Aggressive B-cell Lymphoma With Secondary Involvement of the CNS
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jul 6, 2022

    Lymphoma, Acute Lymphoblastic Leukemia Trial in Worldwide (Apixaban, No systemic anticoagulant prophylaxis)

    Completed
    Has Results
    • Lymphoma
    • Acute Lymphoblastic Leukemia
    • Apixaban
    • No systemic anticoagulant prophylaxis
    • Phoenix, Arizona
    • +95 more
    Feb 10, 2022

    Marginal Zone Lymphoma Trial (Mosunetuzumab + Lenalidomide, - Rituximab + Lenalidomide (28-days cycles, - Rituximab +

    Not yet recruiting
    • Marginal Zone Lymphoma
    • Mosunetuzumab + Lenalidomide
    • +3 more
    • (no location specified)
    Aug 16, 2023

    Refractory Peripheral T-Cell Lymphoma, Relapsed Peripheral T-Cell Lymphoma Trial in Belgium, France (Brentuximab Vedotin -

    Completed
    • Refractory Peripheral T-Cell Lymphoma
    • Relapsed Peripheral T-Cell Lymphoma
    • Brentuximab Vedotin - induction
    • +3 more
    • Antwerpen, Belgium
    • +38 more
    Jan 9, 2023

    B-cell Malignancy, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (AS-1763)

    Not yet recruiting
    • B-cell Malignancy
    • +7 more
    • (no location specified)
    Oct 26, 2022

    CLL/SLL, NHL Trial in China (BN102)

    Not yet recruiting
    • CLL/SLL
    • NHL
    • Guangzhou, China
    • +5 more
    May 4, 2022

    Lymphoma, Large B-Cell, Diffuse Trial in Milan (NGR-hTNF, RITUXIMAB, Doxorubicin)

    Completed
    • Lymphoma, Large B-Cell, Diffuse
    • Milan, Italy
      Ospedale San Raffaele
    Aug 2, 2022

    PET-CT Imaging in Relapsed/Refractory Acute Leukemias

    Not yet recruiting
    • B Cell
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 4, 2023

      Glioblastoma, Squamous Cell Carcinoma, Hodgkin Lymphoma Trial (AVM0703, Hydrocortisone, Proton pump inhibitor)

      Available
      • Glioblastoma
      • +13 more
      • (no location specified)
      Jul 26, 2023

      Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy Trial in United States (Emavusertib, ibrutinib)

      Recruiting
      • Relapsed Hematologic Malignancy
      • Refractory Hematologic Malignancy
      • Phoenix, Arizona
      • +10 more
      Feb 1, 2023